Schizophrenia as a prostaglandin deficiency disease.

Schizophrenia as a prostaglandin deficiency disease.

Famine-Dropsy as a Food-Deficiency Disease.

A case of Hallervorden-Spatz disease presenting as catatonic schizophrenia.

Metabolic bone disease as a result of lactase deficiency.

Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism.

Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.

AhR-deficiency as a cause of demyelinating disease and inflammation.

Evidence of brain dopamine deficiency in schizophrenia.

Diabetes and schizophrenia: genes or zinc deficiency?

Prostaglandin E1 suppression of platelet aggregation response in schizophrenia.

C1-INH defect as an example of deficiency disease.

Clinical zinc deficiency as early presentation of Wilson disease.

Schizophrenia as a disorder of molecular pathways.

Dermatitis artefacta as a symptom of schizophrenia?

HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes.

Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.

[Schizophrenia and Wilson's disease].

Adenosine as a natural prostaglandin antagonist in vascular smooth muscle.

Mental Deficiency as a Community Problem.

Transferrin as a predictor of iron deficiency.

Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.

NNT pseudoexon activation as a novel mechanism for disease in two siblings with familial glucocorticoid deficiency.

AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset.

Inhibition of prostaglandin synthesis as a treatment for biliary pain.

Suggest Documents

Schizophrenia as a prostaglandin deficiency disease.

Famine-Dropsy as a Food-Deficiency Disease.

A case of Hallervorden-Spatz disease presenting as catatonic schizophrenia.

Metabolic bone disease as a result of lactase deficiency.

Vitamin-D Deficiency As a Potential Environmental Risk Factor in Multiple Sclerosis, Schizophrenia, and Autism.

Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients.

AhR-deficiency as a cause of demyelinating disease and inflammation.

Evidence of brain dopamine deficiency in schizophrenia.

Diabetes and schizophrenia: genes or zinc deficiency?

Prostaglandin E1 suppression of platelet aggregation response in schizophrenia.

C1-INH defect as an example of deficiency disease.

Clinical zinc deficiency as early presentation of Wilson disease.

Schizophrenia as a disorder of molecular pathways.

Dermatitis artefacta as a symptom of schizophrenia?

HLA DRB1*03 as a possible common etiology of schizophrenia, Graves' disease, and type 2 diabetes.

Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders.

[Schizophrenia and Wilson's disease].

Adenosine as a natural prostaglandin antagonist in vascular smooth muscle.

Mental Deficiency as a Community Problem.

Transferrin as a predictor of iron deficiency.

Ovarian 17-ketosteroid reductase deficiency as a possible cause of polycystic ovarian disease.

NNT pseudoexon activation as a novel mechanism for disease in two siblings with familial glucocorticoid deficiency.

AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset.

Inhibition of prostaglandin synthesis as a treatment for biliary pain.

Schizophrenia as a prostaglandin deficiency disease.

Recommend Documents

Follow Us